Acceptance of vaccination during pregnancy: Experience with 2009 influenza A (H1N1) in the Netherlands

Vaccine

Volumn 30, Issue 18, 2012, Pages 2892-2899

  van Lier, Alies ^a   Steens, Anneke ^a   Ferreira, José A ^a   van der Maas, Nicoline A T ^a   de Melker, Hester E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Influenza A (H1N1); Intention; Pregnancy; Vaccination coverage

Indexed keywords

2009 H1N1 INFLUENZA; AGE DISTRIBUTION; ARTICLE; FEMALE; HEALTH BELIEF; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MULTIPARA; NETHERLANDS; ONLINE MONITORING; PHILOSOPHY; PREDICTIVE VALUE; PREGNANCY DISORDER; PRENATAL CARE; PRIORITY JOURNAL;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERNET; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; VACCINATION;

EID: 84859002116     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.030     Document Type: Article

References (33)

1. General recommendations on immunization - Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(2):1-64.
2. Silveira C.M., Caceres V.M., Dutra M.G., Lopes-Camelo J., Castilla E.E. Safety of tetanus toxoid in pregnant women: a hospital-based case-control study of congenital anomalies. Bull World Health Organ 1995, 73(5):605-608.
3. Czeizel A.E., Rockenbauer M. Tetanus toxoid and congenital abnormalities. Int J Gynaecol Obstet 1999, 64(3):253-258.
4. Munoz F.M., Greisinger A.J., Wehmanen O.A., Mouzoon M.E., Hoyle J.C., Smith F.A., et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005, 192(4):1098-1106.
5. Tamma P.D., Ault K.A., del Rio C., Steinhoff M.C., Halsey N.A., Omer S.B. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009, 201(6):547-552.
6. Naleway A.L., Smith W.J., Mullooly J.P. Delivering influenza vaccine to pregnant women. Epidemiol Rev 2006, 28:47-53.
7. Lu P., Bridges C.B., Euler G.L., Singleton JA Influenza vaccination of recommended adult populations U.S., 1989-2005. Vaccine 2008, 26(14):1786-1793.
8. Blanchard-Rohner G., Siegrist C.A. Vaccination during pregnancy to protect infants against influenza: why and why not?. Vaccine 2011, 29(43):7542-7550.
9. Mak T.K., Mangtani P., Leese J., Watson J.M., Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 2008, 8(1):44-52.
10. WHO Influenza vaccines: WHO position paper. Wkly Epidemiol Rec 2005, 80(33):277-288.
11. Kelly H., Mercer G., Cheng A Quantifying the risk of pandemic influenza in pregnancy and indigenous people in Australia in 2009. Euro Surveill 2009, 14(50).
12. Jamieson D.J., Honein M.A., Rasmussen S.A., Williams J.L., Swerdlow D.L., Biggerstaff M.S., et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374(9688):451-458.
13. Health Council of the Netherlands. Advice vaccination against pandemic influenza A/H1N1 2009: target groups and prioritizing (publication 2009/16). Den Haag: Health Council of the Netherlands; 2009.
14. EMA. Focetria: EPAR - Product Information. London: EMA; 2011. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000710/WC500023749.pdf.
15. van Leeuwen N, Zuurmond M, Melser C. General practitioner for most people close by home. CBS Webmagazine 2009. http://www.cbs.nl/nl-NL/menu/themas/dossiers/nederland-regionaal/publicaties/artikelen/archief/2009/2009-2791-wm.htm.
16. Steens A., Wijnans E.G., Dieleman J.P., Sturkenboom M.C.J.M., van der Sande M.A.B., van der Hoek W Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 influenza A/H1N1-related hospitalisation; a matched case-control study. BMC Infect Dis 2011, 11(1):196.
17. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995, 57(1):289-300.
18. Liaw A, Wiener M. Classification and regression by randomForest. R News. 2002;2/3.
19. Statistics Netherlands Survey working population: educational level 2010 by sex and age 2011, Statistics Netherlands, Den Haag.
20. The Netherlands Perinatal Registry. Perinatal Care in the Netherlands 2008. Utrecht: the Netherlands Perinatal Registry; 2011.
21. Statistics Netherlands Population on 01-01-2010 2011, Statistics Netherlands, Den Haag.
22. White S.W., Petersen R.W., Quinlivan J.A. Pandemic (H1N1) 2009 influenza vaccine uptake in pregnant women entering the 2010 influenza season in Western Australia. Med J Aust 2010, 193(7):405-407.
23. Simpson C.R., Ritchie L.D., Robertson C., Sheikh A., McMenamin J. Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. Health Technol Assess 2010, 14(34):313-346.
24. Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women - 10 states, 2009-10 influenza season. MMWR Morb Mortal Wkly Rep 2010;59(47):1541-5.
25. Fabry P., Gagneur A., Pasquier J.C. Determinants of A (H1N1) vaccination: cross-sectional study in a population of pregnant women in Quebec. Vaccine 2011, 29(9):1824-1829.
26. van der Weerd W., Timmermans D.R., Beaujean D.J., Oudhoff J., van Steenbergen J.E. Monitoring the level of government trust, risk perception and intention of the general public to adopt protective measures during the influenza A (H1N1) pandemic in the Netherlands. BMC Public Health 2011, 11:575.
27. Moro P.L., Broder K., Zheteyeva Y., Revzina N., Tepper N., Kissin D., et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 2011, 205(5):e1-e9.
28. Chanel O., Luchini S., Massoni S., Vergnaud J.C. Impact of information on intentions to vaccinate in a potential epidemic: Swine-origin Influenza A (H1N1). Soc Sci Med 2011, 72(2):142-148.
29. Fridman D., Steinberg E., Azhar E., Weedon J., Wilson T.E., Minkoff H. Predictors of H1N1 vaccination in pregnancy. Am J Obstet Gynecol 2011, 204(6 Suppl 1). S124-7.
30. Kwon Y., Cho H.Y., Lee Y.K., Bae G.R., Lee S.G. Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate. Vaccine 2010, 29(2):161-165.
31. Ahluwalia I.B., Jamieson D.J., Rasmussen S.A., D'Angelo D., Goodman D., Kim H. Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet Gynecol 2010, 116(4):949-955.
32. Broughton D.E., Beigi R.H., Switzer G.E., Raker C.A., Anderson B.L. Obstetric health care workers' attitudes and beliefs regarding influenza vaccination in pregnancy. Obstet Gynecol 2009, 114(5):981-987.
33. van 't Klooster T.M., Wielders C.C., Donker T., Isken L., Meijer A., van den Wijngaard C.C., et al. Surveillance of hospitalisations for 2009 pandemic influenza A(H1N1) in the Netherlands, 5 June-31 December 2009. Euro Surveill 2010, 15(2).